HyperWeb‘s senior financial analyst reviewed the merger disclosure that followed a blockbuster quarter at SpaceX. The company’s chief executive said independent committees at both SpaceX and Tesla are now weighing a combination. SpaceX shares rose about 8% after hours, while Tesla gained roughly 1.8%.

The disclosure turns months of speculation into a formal process. It also leaves price, structure, and timing completely open. The chief executive called any assumption of certainty an overstatement.

What a Special Committee Does

A special committee hands deal evaluation to independent directors. Independent review is standard when one executive stands on both sides of a transaction. SpaceX’s chief executive said he is recused because of that conflict.

Both boards formed their committees at shareholders’ request. Such committees typically hire their own advisers and can recommend against a deal. No terms have been agreed.

Committees often weigh a fairness opinion from an outside bank. That opinion tests whether the price falls inside a reasonable range.

Formation of a committee is a first step, not an agreement. Reviews of this kind can end with or without a transaction. Investors should treat the news as a process milestone.

A Quarter That Set the Stage

SpaceX reported third-quarter revenue of $14.58 billion, up 161% from a year earlier. Wall Street had expected roughly $12.7 billion. Net income reached $4.4 billion.

The artificial intelligence business grew about ninefold, a pace that helped lift the total. Extended trading added 8% to the results. Investors evidently read the earnings and the merger news together.

What the Numbers Imply

Backing out the growth rate gives a year-earlier revenue base near $5.6 billion. The quarter therefore added roughly $9 billion of new sales in twelve months. Revenue also landed about 15% above what analysts expected.

Net income of $4.4 billion equals a margin near 30%. Yet capital spending exceeded profit by about $15 billion. Closing that gap takes cash reserves, debt, or new equity.

Spending Outruns Sales

Capital spending reached $19.6 billion in the quarter. That is about 1.3 times revenue, so spending ran ahead of sales by a wide margin. The gap shows how capital-hungry the business remains.

Forecasts point to as much as $40 billion of spending in the current quarter. That would be nearly three times the revenue just reported. A merged company would inherit that appetite for capital.

Spending of that scale also shapes financing. Large builds of data centers and chip plants consume cash long before they produce revenue. Investors will watch how any combined company funds them.

The Voting Gap

Control differs sharply between the two companies. SpaceX’s chief executive holds more than 80% of voting power there, but only about 20% at Tesla. That imbalance makes the exchange ratio a sensitive issue for Tesla shareholders.

On the Tesla side, a deal would need approval from a majority of all outstanding shares. The chief executive called that a high hurdle. Tesla’s annual proxy statement contains no merger proposal.

Suppose the chief executive’s roughly 20% stake backs a deal. Other holders would still need to supply about 30% of all outstanding shares. Under that standard, a share that goes unvoted works like a no.

The exchange ratio sets how many shares of one company a holder of the other would receive. A generous ratio for one side costs the other. Independent advisers usually test that figure against several valuation methods.

Regulators Will Look Closely

Any agreement would face review in the United States, Europe, and China. Tesla’s factories in China and SpaceX’s American government contracts complicate that path. Analysts flag national security concerns as the main regulatory bottleneck.

Deal size adds another layer. Commentators describe a combined value near $3.5 trillion, which would exceed any merger on record. Such a transaction would draw intense scrutiny from every agency involved.

Review timelines vary by agency and region. Each regulator can request documents and extend its clock. A deal of this size would likely face parallel reviews.

Three Paths From Here

A signed agreement is the first path, triggering shareholder votes and regulatory filings. A second path ends the review with no deal, leaving both companies independent. A third path stretches the process while advisers and committees negotiate.

Each outcome carries a different price reaction. Shares often move before terms appear, so early gains can fade. Disciplined holders tend to wait for documents rather than headlines.

What Allocators Should Weigh

For portfolios holding either stock, the merger file adds event risk to existing positions. Outcomes range from a signed agreement to no deal at all. Timing remains unknown, and regulatory review would follow any announcement.

Position sizing deserves attention before terms arrive. Holders of one company could end up owning the other through a share exchange. Diversified mandates can limit the damage if the market reprices either name sharply.